TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07283367: A Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-20110 Combination Therapies in Patients With Advanced Colorectal Cancer.

Sponsor: Hansoh BioMedical R&D Company · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 502 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07283367 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07283367 Rescue Dossier →